2022 first quarter : Income increase by 55%

2 years ago

Press Release        Ecully, April 15, 2022 – 10 am Continued growth in Q1 2022Q1 2022 revenues up +55% In thousands of…

Immunicum AB: Immunicum AB (publ) Publishes the Annual Report for 2021

2 years ago

Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat established tumors, today announced…

EssilorLuxottica: Leadership changes announced at GrandVision

2 years ago

Leadership changes announced at GrandVision Charenton-le-Pont, France, and Schiphol, The Netherlands (April 15, 2022 – 8 am CET) – EssilorLuxottica…

Koelis Announces Completes of €10 Million Follow-On Growth Equity Financing with InnovaHealth Partners

2 years ago

GRENOBLE, France and PRINCETON, N.J., April 14, 2022 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”) announced today the…

LIXTE Biotechnology Announces the Closing of $5.8 Million Registered Direct Offering Priced At-The-Market

2 years ago

PASADENA, CA, April 14, 2022 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery company developing…

Sienna Announces First Quarter 2022 Results Release Date and Conference Call

2 years ago

MARKHAM, Ontario, April 14, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced that…

Christina Lake Cannabis Corp. Files Financial Statements for the Year Ended November 30, 2021

2 years ago

VANCOUVER, British Columbia, April 14, 2022 (GLOBE NEWSWIRE) -- (CSE: CLC) -- Christina Lake Cannabis Corp. (the “Corporation or “Christina…

Monthly information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2022

2 years ago

     Monthly information regarding the total number of voting rights and total number of shares of the Company as…

Pasithea Therapeutics to Present at the NobleCon18 Investor Conference 2022

2 years ago

MIAMI BEACH, Fla., April 14, 2022 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a novel…

CytomX Therapeutics Announces Retirement of John A. Scarlett, M.D. from Board of Directors

2 years ago

SOUTH SAN FRANCISCO, Calif., April 14, 2022 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field…